These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 29128063)

  • 1. Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Esterson YB; Grimaldi GM
    Clin Liver Dis; 2018 Feb; 22(1):93-108. PubMed ID: 29128063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?
    Ajmera V; Loomba R
    Semin Liver Dis; 2018 Feb; 38(1):14-20. PubMed ID: 29471562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiologic evaluation of nonalcoholic fatty liver disease.
    Lee SS; Park SH
    World J Gastroenterol; 2014 Jun; 20(23):7392-402. PubMed ID: 24966609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of nonalcoholic fatty liver disease and its clinical utility.
    Chartampilas E
    Hormones (Athens); 2018 Mar; 17(1):69-81. PubMed ID: 29858854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
    Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
    Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).
    Han MA; Saouaf R; Ayoub W; Todo T; Mena E; Noureddin M
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):379-390. PubMed ID: 28277807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Application of Quantitative MR Imaging in Nonalcoholic Fatty Liver Disease.
    Tsujita Y; Sofue K; Ueshima E; Ueno Y; Hori M; Murakami T
    Magn Reson Med Sci; 2023 Oct; 22(4):435-445. PubMed ID: 35584952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications.
    Ballestri S; Romagnoli D; Nascimbeni F; Francica G; Lonardo A
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):603-27. PubMed ID: 25694178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
    Tsai E; Lee TP
    Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACR Appropriateness Criteria
    ; Horowitz JM; Kamel IR; Arif-Tiwari H; Asrani SK; Hindman NM; Kaur H; McNamara MM; Noto RB; Qayyum A; Lalani T
    J Am Coll Radiol; 2017 May; 14(5S):S103-S117. PubMed ID: 28473066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
    Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear Wave Elastography for Assessment of Steatohepatitis and Hepatic Fibrosis in Rat Models of Non-Alcoholic Fatty Liver Disease.
    Kang BK; Lee SS; Cheong H; Hong SM; Jang K; Lee MG
    Ultrasound Med Biol; 2015 Dec; 41(12):3205-15. PubMed ID: 26349582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRE in NAFLD: Promising but Further Validation is Required.
    Ryan JD; Tsochatzis EA
    Ann Hepatol; 2017; 16(3):331-332. PubMed ID: 28425401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of Nonsurveillance and Advanced Hepatocellular Carcinoma at Diagnosis in Chronic Liver Disease.
    Huang Y; Wallace MC; Adams LA; MacQuillan G; Garas G; Ferguson J; Samuelson S; Tibballs J; Jeffrey GP
    J Clin Gastroenterol; 2018 Jul; 52(6):551-556. PubMed ID: 28858944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of fibrosis during the development of fatty liver in rabbits using real-time shear-wave elastography.
    Lu YP; Wei J; Xu LR; Tang YY; Yuan Y; Zhang Y; Li YY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):921-928. PubMed ID: 25480592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to Diagnose Nonalcoholic Fatty Liver Disease.
    de Alwis NM; Anstee QM; Day CP
    Dig Dis; 2016; 34 Suppl 1():19-26. PubMed ID: 27547937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).
    Cannella R; Borhani AA; Tublin M; Behari J; Furlan A
    Abdom Radiol (NY); 2019 May; 44(5):1816-1824. PubMed ID: 30788556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
    Ajmera VH; Liu A; Singh S; Yachoa G; Ramey M; Bhargava M; Zamani A; Lopez S; Mangla N; Bettencourt R; Rizo E; Valasek M; Behling C; Richards L; Sirlin C; Loomba R
    Hepatology; 2020 Mar; 71(3):849-860. PubMed ID: 31556124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.
    Golabi P; Sayiner M; Fazel Y; Koenig A; Henry L; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):63-71. PubMed ID: 26469309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.